QuidelOrtho Corporation

NASDAQ:QDEL

Medical - Instruments & Supplies

Healthcare
$9.57 +0.72%

+$0.09 today

Market cap
$656.62M
Beta
0.76
P/E (TTM)
-0.7
EPS (TTM)
-$17.76
52W Low $9.92High $35.58

Volume 2.13M

Average 2.35M

QDEL Debt Repayment

Cash used to repay borrowings during the period.

QuidelOrtho CorporationNASDAQ: QDEL

Debt Repayment · Q1 FY2026 · quarter ended Mar 2026

Debt repayment growth accelerates

Q1 FY2026 debt repayment of $36.9M rose 130.6% year over year, ahead of the +53.6% change in trailing-twelve-month debt repayment. Over 3 fiscal years it compounded at -23.5% a year.

Context

  • Debt repayment amounted to 5.7% of revenue in FY2025, up 3.8 pp from a year earlier.
  • Debt repayment increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +130.6% holds above the trailing-twelve-month pace of +53.6%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$36.9M+441.7% QoQ
Last fiscal yearDec 2025
$155.1M+190.4% YoY
LTMMar 2026
$176M+53.6% YoY
Debt Repayment past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+130.6%——
1 year+190.4%——
3-year CAGR-23.5%——
5-year CAGR——
10-year CAGR——

Debt Repayment history

USD · from the cash flow

Latest · FY2025
155.1M USD
Year-over-year change
+190.4%

Debt Repayment vs competitors

How QDEL compares with its peers on the latest reported figures

  • QDEL's LTM Mar 2026 debt repayment of $176M is the 3rd largest of the 9 companies compared; the peer median is $35K.
  • Its year-over-year change of +53.6% is the 4th highest of 8, against a peer median of -45.6%.
  • Debt repayment amounts to 6.6% of revenue for QDEL, versus a peer median of 2.1%.
QDEL Competitors Peer median
Debt Repayment for QDEL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TMOThermo Fisher Scientific Inc.LTM Sep 2026$3.89B +218.5%+101.5%8.2%
DGXQuest Diagnostics IncorporatedLTM Sep 2026$489M +181.2%+570.2%4.1%
QDELQuidelOrtho CorporationLTM Mar 2026$176M +53.6%-23.5%6.6%
OPKOPKO Health, Inc.LTM Mar 2026$67.04M -132.8%—11.5%
TRIBTrinity Biotech plcLTM Dec 2025$15.05M -45.6%—34.3%
BIOBio-Rad Laboratories, Inc.LTM Jun 2026$900K +94.0%—0.0%
RVTYRevvity, Inc.LTM Jul 2026$418K -99.9%-90.2%0.0%
OSUROraSure Technologies, Inc.LTM Mar 2026$70K -91.3%-64.7%0.1%
NNNNAnbio Biotechnology Class A Ordinary SharesFY2025$0 ——0.0%
Peer median (excluding QDEL) $35K-45.6%+18.4%2.1%

Competitors are the stored peer set for QDEL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Jan 2023
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income704.23M548.7M(10.1M)(2.05B)(1.13B)
Depreciation & Amortization54.38M283.6M457.2M453.4M442M
Deferred Income Tax24.67M(44M)(11.6M)(99.3M)6.3M
Stock-Based Compensation25.4M48.4M51.6M42.1M45.9M
Change in Working Capital(2.78M)(53.2M)(194.9M)(158.7M)(125.8M)
Accounts Receivables118.85M150.2M160M5.4M(117.5M)
Inventory(85.04M)(116.9M)(211.6M)(134.1M)(148.3M)
Accounts Payables10.45M23.5M3M(23.4M)40M
Other Working Capital(47.04M)(110M)(146.3M)(6.6M)100M
Other Non-Cash Items(34K)101.8M(12M)1.9B868.6M
Operating Cash Flow805.87M885.3M280.2M83M105.2M
Capital Expenditures(292.72M)(140.9M)(209.3M)(195.1M)(188.2M)
Acquisitions (Net)0(1.51B)006.5M
Purchases of Investments(67.45M)(63.7M)(60.1M)(7.2M)0
Sales of Investments3.76M53.4M78.3M63.1M0
Other Investing Activities36.88M18.4M3.5M(10.7M)(11M)
Investing Cash Flow(319.53M)(1.64B)(187.6M)(149.9M)(192.7M)
Debt Repayment(300K)346.2M(226.4M)53.4M155.1M
Common Stock Issued7.6M26.4M11.6M5M6.1M
Common Stock Repurchased(103.44M)(74.3M)(7.2M)00
Dividends Paid00000
Other Financing Activities(76.99M)(46.3M)(43.8M)(9.6M)(5.4M)
Financing Cash Flow(173.18M)252M(265.8M)48.8M155.8M
Effect of Forex Changes(352K)(2M)(1.2M)(2.9M)3M
Net Change in Cash312.81M(508.9M)(174.4M)(21M)71.3M
Free Cash Flow513.15M744.4M70.9M(112.1M)(83M)

QuidelOrtho Corporation

NASDAQ:QDEL

Intrinsic Alpha fair value

Locked

Current Price

$9.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.